NDC 50090-4453-01 - PROMETHAZINE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-4453
- Requested NDC
- 50090-4453-01
- Package NDCs from labels
- 50090-4453-0, 50090-4453-1, 50090-4453-5, 50090-4453-6, 50090-4453-9, 50090-4453-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2023-05-08
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| PROMETHAZINE HYDROCHLORIDE - A-S Medication Solutions | A-S Medication Solutions | 2023-05-08 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50090-4453-0 | 2023-02-07 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
| 50090-4453-1 | 2023-02-07 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
| 50090-4453-5 | 2023-02-07 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
| 50090-4453-6 | 2023-02-07 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
| 50090-4453-9 | 2023-02-07 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
| 50090-4453-0 | 2023-01-30 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
| 50090-4453-1 | 2023-01-30 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
| 50090-4453-5 | 2023-01-30 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
| 50090-4453-6 | 2023-01-30 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
| 50090-4453-9 | 2023-01-30 | PROMETHAZINE HYDROCHLORIDE TABLETS, USP |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-4453-0 | PROMETHAZINE HYDROCHLORIDE | 12 in 1 BOTTLE | TABLET | 12 | 10 | |
| 50090-4453-1 | PROMETHAZINE HYDROCHLORIDE | 10 in 1 BOTTLE | TABLET | 10 | 10 | |
| 50090-4453-5 | PROMETHAZINE HYDROCHLORIDE | 60 in 1 BOTTLE | TABLET | 60 | 10 | |
| 50090-4453-6 | PROMETHAZINE HYDROCHLORIDE | 20 in 1 BOTTLE | TABLET | 20 | 10 | |
| 50090-4453-9 | PROMETHAZINE HYDROCHLORIDE | 30 in 1 BOTTLE | TABLET | 30 | 10 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-4453 | PROMETHAZINE HYDROCHLORIDE TABLET [A-S MEDICATION SOLUTIONS] | 10 | Current NDC, Legacy NDC, 5 package rows | 20230510_2c9a4767-23c4-4a1c-bb4c-2bad1351c270.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-4453-0 | EA - Each | 50090-4453 | 3ffe64ed-ce71-4fd7-909e-daa67e6162fe | 1 | 2023-06-06 |
| 50090-4453-1 | EA - Each | 50090-4453 | 8d71d7c6-5e0e-4232-a875-282f6f8b3aa0 | 1 | 2023-06-06 |
| 50090-4453-5 | EA - Each | 50090-4453 | c08f392c-6799-4aa4-962d-f706acd1b2c0 | 1 | 2023-06-06 |
| 50090-4453-6 | EA - Each | 50090-4453 | c0815672-d3aa-436f-b6f2-ca6ca1b0a203 | 1 | 2023-06-06 |
| 50090-4453-9 | EA - Each | 50090-4453 | e1346423-ed2b-4b72-aeb5-59b5a4080029 | 1 | 2023-06-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Promethazine Hydrochloride | PROMETHAZINE HYDROCHLORIDE | BluePoint Laboratories | 44cd6d46-fbb9-4836-9426-d8ce2cb6d66d | 2025-09-12 | Boxed warning, Warnings, Adverse reactions | 992475 992447 992438 R61ZEH7I1I |
| Promethazine Hydrochloride and Dextromethorphan Hydrobromide | PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | ANI Pharmaceuticals, Inc. | a52e210f-b99d-493e-b679-ec565c6ff72d | 2025-08-08 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| Promethazine Hydrochloride | PROMETHAZINE HYDROCHLORIDE | PAI Holdings, LLC dba PAI Pharma | 7a186bcd-ab8c-4695-8289-4cd33bb551cf | 2025-08-05 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| Promethazine Hydrochloride | PROMETHAZINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 13d9e59d-eadb-41d5-9f47-9c11a6efb31c | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| Promethazine Hydrochloride | PROMETHAZINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | d545105f-27dc-4820-b0b1-fcf17e0be0f0 | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| PHENERGAN | PROMETHAZINE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 6f7e47cc-f823-4336-8107-f980e3049617 | 2025-06-30 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| Promethazine Hydrochloride | PROMETHAZINE HYDROCHLORIDE | Asclemed USA, Inc. | 1b1cee64-c0b5-4da6-92d0-1769350a5181 | 2025-06-07 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| Promethazine Hydrochloride and Codeine Phosphate | PROMETHAZINE HYDROCHLORIDE AND CODEINE PHOSPHATE | ATLANTIC BIOLOGICALS CORP. | f8fb13e3-bc09-4004-a911-a38b6bbb0058 | 2025-06-04 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| Promethazine DM | PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | PAI Holdings, LLC dba PAI Pharma | 1d47280d-28c9-4701-8c5f-a6e6b524083b | 2025-05-31 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| Promethazine Hydrochloride and Dextromethorphan Hydrobromide | PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | Asclemed USA, Inc. | 702eb7c0-db4c-4729-b69e-99f64c63c7bd | 2025-05-07 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | Xttrium Laboratories, Inc. | 302bfea2-d403-d315-e063-6294a90a37dd | 2025-04-07 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| Promethazine Hydrochloride and Dextromethorphan Hydrobromide | PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | Xttrium Laboratories, Inc | 30c9d769-bc74-04d2-e063-6294a90a665a | 2025-04-07 | Warnings, Adverse reactions | R61ZEH7I1I |
| PROMETHAZINE HYDROCHLORIDE | PROMETHAZINE HYDROCHLORIDE | Kesin Pharma Corporation | 28793bd2-bd40-4571-e063-6394a90ae789 | 2025-03-13 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| Promethazine Hydrochloride | PROMETHAZINE HYDROCHLORIDE | NuCare Pharmaceuticals,Inc. | 74834e1b-0d90-0542-e053-2991aa0aa1ef | 2025-02-10 | Warnings, Adverse reactions | 992447 R61ZEH7I1I |
| Promethazine Hydrochloride | PROMETHAZINE HYDROCHLORIDE | Coupler LLC | 2d996287-9eed-265a-e063-6294a90a6969 | 2025-02-07 | Boxed warning, Warnings, Adverse reactions | 992475 R61ZEH7I1I |
| Promethazine Hydrochloride and Dextromethorphan Hydrobromide Oral Solution | PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE ORAL SOLUTION | NuCare Pharmaceuticals,Inc. | 0b7bfbab-decb-970c-e063-6394a90a50ef | 2025-02-03 | Boxed warning, Warnings, Adverse reactions | R61ZEH7I1I |
| Promethazine Hydrochloride | PROMETHAZINE HYDROCHLORIDE | Advanced Rx Pharmacy of Tennessee, LLC | f4c23037-e415-7604-e053-2995a90a5bb6 | 2024-12-31 | Warnings, Adverse reactions | 992447 R61ZEH7I1I |
| Promethazine Hydrochloride | PROMETHAZINE HYDROCHLORIDE | Zydus Lifesciences Limited | 4eaa8291-9cde-4205-857b-925ea8d618ba | 2024-12-04 | 992475 992447 992438 R61ZEH7I1I | |
| Promethazine Hydrochloride and Phenylephrine Hydrochloride | PROMETHAZINE AND PHENYLEPHRINE | Amneal Pharmaceuticals LLC | cf4ef7c0-2f4a-4b0f-9060-ad0b909d1ed4 | 2024-10-30 | Warnings, Adverse reactions | R61ZEH7I1I |
| Promethazine Hydrochloride and Dextromethorphan Hydrobromide | PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE | Amneal Pharmaceuticals LLC | 6081c216-0bed-40f0-8732-f999647003d5 | 2024-10-30 | Warnings, Adverse reactions | R61ZEH7I1I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.